Disease Outcomes of Hepatitis Delta Genotype 5 vs Genotype 1
Patients with hepatitis delta virus (HDV) genotype 5 have demonstrated improved prognoses, better responses to pegylated interferon treatment.
All articles by Infectious Disease Advisor Contributing Writer
Median 5-Day Incubation Period for COVID-19
The median incubation period for coronavirus disease 2019 (COVID-19) is approximately 5 days, according to study results published in medRxiv. The first case of COVID-19 was identified in China in December 2019; however, there are limited data on the incubation period for COVID-19, which has estimated the range to be between 2 days and 14 days.…
Long-Acting Reversible Contraceptives Not Linked to Increased STIs Among Teens
The risk of acquiring a sexually transmitted infection (STI) is not higher among adolescents using long-acting reversible contraceptives.
Low Screening Rates for HIV and Hepatitis C in Patients Who Inject Drugs
Screening for HIV and hepatitis C virus in medical clinics or emergency departments is infrequent among patients with indicators for injection-drug use.
Multiple Sclerosis Susceptibility Associated With Certain Gut Bacteria
A network of gut bacteria species may be associated with host genetic factors that increase susceptibility to multiple sclerosis.
2019-nCoV More Likely to Affect Older Men With Chronic Illnesses
Infections with the 2019 novel coronavirus (2019-nCoV) was of clustering onset and more likely to affect older men with comorbid diseases.
Changes in Microbiota Predictive of Recurrent C Difficile Infection Risk
Features of fecal microbiota at baseline and after antibiotic therapy may be predictive of recurrent Clostridiodes difficile infection in patients with and without ulcerative colitis.
To Prepare for Novel 2019 Coronavirus Transmissions, Look to the Past
High transmissibility and high severity are the 2 most critical factors for determining the effect of a viral outbreak; no recent pandemics have been both.
Oseltamivir Not Linked to Increase Risk for Neuropsychiatric Events
No difference was seen in the risk for serious neuropsychiatric events in patients who received oseltamivir in the 30 days after influenza diagnosis compared with those who did not.
The 2019 Coronavirus Outbreak: Public Health Response and Clinical Guidance
The Centers for Disease Control and Prevention (CDC) and other federal, state, and local departments and agencies are taking aggressive measures to slow transmission in the United States.
-
Loading...
-
Loading...
Next post in Respiratory
